4//SEC Filing
Epizyme, Inc. 4
Accession 0001209191-14-053496
CIK 0001571498operating
Filed
Aug 18, 8:00 PM ET
Accepted
Aug 19, 6:20 PM ET
Size
8.8 KB
Accession
0001209191-14-053496
Insider Transaction Report
Form 4
Epizyme, Inc.EPZM
Hedrick Eric
Chief Medical Officer
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2014-08-15−2,000→ 280,500 totalExercise: $2.19Exp: 2022-06-06→ Common Stock (2,000 underlying) - Sale
Common Stock, par value $0.0001 per share
2014-08-15$38.60/sh−2,000$77,200→ 0 total - Exercise/Conversion
Common Stock, par value $0.0001 per share
2014-08-15$2.19/sh+2,000$4,380→ 2,000 total
Footnotes (2)
- [F1]The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- [F2]This option was granted on June 7, 2012 with respect to 300,000 shares of Common Stock, with 25% vesting on May 8, 2013 and the remaining 75% vesting in 36 substantially equal monthly installments thereafter.
Documents
Issuer
Epizyme, Inc.
CIK 0001571498
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001571498
Filing Metadata
- Form type
- 4
- Filed
- Aug 18, 8:00 PM ET
- Accepted
- Aug 19, 6:20 PM ET
- Size
- 8.8 KB